Endra Life Sciences Inc (NDRA)

Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	31.77%1.48	2.17	1.62	1.37	1.30
Research and Development	69.90%0.23	0.78	0.51	0.43	0.38
Operating Income/Loss	31.77%-1.48	-2.17	-1.62	-1.37	-1.30
Nonoperating Income/Loss	90.56%1.64	0.86	-1.55	-0.23	-
Income/Loss From Continuing Operations Before Tax	112.20%0.16	-1.31	-3.17	-1.60	-1.23
	112.20%0.16	-1.31	-3.17	-1.60	-1.23
Attributable To Parent	112.20%0.16	-1.31	-3.17	-1.60	-1.23
Basic Average Shares	10.38%1.32	1.20	-	0.76	-
Diluted Average Shares	106.34%2.48	1.20	-	0.76	-
Basic Earnings Per Share	111.01%0.12	-1.09	-	-2.10	-
Diluted Earnings Per Share	105.50%0.06	-1.09	-	-2.10	-